Evolutionary Genomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Evolutionary Genomics, Inc. reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 133.33 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2023-03-09
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-12-31 was 0.00 shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-09-30 was 0.00 shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-06-30 was 0.00 shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-03-31 was 133.33K shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 133.33K shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2021 was 0.00 shares.
- Evolutionary Genomics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2020 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-09 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-09 | 133.33K shares 10-K · filed 2023-03-09 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | 0.00 shares derived: sum of 2 quarters · filed 2022-10-21 | 133.33K shares 10-Q · filed 2022-10-21 | 133.33K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 133.33K shares 10-Q · filed 2022-08-08 | 133.33K shares derived: sum of 3 quarters · filed 2023-03-09 | 133.33K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-03-31 | 133.33K shares 10-Q · filed 2022-05-16 | 133.33K shares derived: sum of 2 quarters · filed 2023-03-09 | 133.33K shares derived: sum of 3 quarters · filed 2023-03-09 | 133.33K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-09 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-09 | 0.00 shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | 0.00 shares derived: sum of 2 quarters · filed 2022-10-21 | 0.00 shares 10-Q · filed 2022-10-21 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 0.00 shares 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-22 | |||
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-13 |